An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-02-25
DOI
10.1038/s41598-022-07334-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
- (2021) Lianghao Zhang et al. Frontiers in Oncology
- Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
- (2021) Kuo-Hao Ho et al. BMC Medicine
- Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancer
- (2021) Wen‐Jie Luo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Competitive glucose metabolism as a target to boost bladder cancer immunotherapy
- (2020) Julieta Afonso et al. Nature Reviews Urology
- A Novel lncRNA ENST00000512916 Facilitates Cell Proliferation, Migration and Cell Cycle Progression in Ameloblastoma
- (2020) Yan Sun et al. OncoTargets and Therapy
- Downregulated miR-524-5p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis
- (2020) Lijie Chen et al. MEDICAL SCIENCE MONITOR
- An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
- (2020) Wen Jiang et al. Cancer Medicine
- Computational recognition of lncRNA signature of tumor-infiltrating B lymphocytes with potential implications in prognosis and immunotherapy of bladder cancer
- (2020) Meng Zhou et al. BRIEFINGS IN BIOINFORMATICS
- TIMER2.0 for analysis of tumor-infiltrating immune cells
- (2020) Taiwen Li et al. NUCLEIC ACIDS RESEARCH
- Treatment of muscle‐invasive and advanced bladder cancer in 2020
- (2020) Vaibhav G. Patel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)
- (2020) Rui Cao et al. Cancer Cell International
- Non-coding RNA in bladder cancer
- (2020) Yi Li et al. CANCER LETTERS
- Myeloid-derived suppressor cells are essential partners for immune checkpoint inhibitors in the treatment of cisplatin-resistant bladder cancer
- (2020) Yuji Takeyama et al. CANCER LETTERS
- A Five-Gene Signature Based on Stromal/Immune Scores in the Tumor Microenvironment and Its Clinical Implications for Liver Cancer
- (2020) Xichun Liu et al. DNA AND CELL BIOLOGY
- Immune-related lncRNA to construct novel signature and predict the immune landscape of human hepatocellular carcinoma
- (2020) Weifeng Hong et al. Molecular Therapy-Nucleic Acids
- Comprehensive Analysis of the Expression, Relationship to Immune Infiltration and Prognosis of TIM-1 in Cancer
- (2020) Xiaoxiao Kong et al. Frontiers in Oncology
- Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer
- (2020) Yucai Wu et al. Aging-US
- Identification and verification of an immune-related lncRNA signature for predicting the prognosis of patients with bladder cancer
- (2020) Jirong Wang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Inhibition of LINC00994 represses malignant behaviors of pancreatic cancer cells: interacting with miR-765-3p/RUNX2 axis
- (2019) Xuan Zhu et al. CANCER BIOLOGY & THERAPY
- Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data
- (2019) Francesca Finotello et al. Genome Medicine
- Tumor‑infiltrating M2�macrophages driven by specific genomic alterations are associated with prognosis in bladder cancer
- (2019) Yongping Xue et al. ONCOLOGY REPORTS
- The MHC class I‐LILRB1 signalling axis as a promising target in cancer therapy
- (2019) Jinming Zhao et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- A six-gene prognostic model predicts overall survival in bladder cancer patients
- (2019) Liwei Wang et al. Cancer Cell International
- The multifaceted immune regulation of bladder cancer
- (2019) Anna K. Schneider et al. Nature Reviews Urology
- An EMT‐related gene signature for the prognosis of human bladder cancer
- (2019) Rui Cao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Ensembl 2020
- (2019) Andrew D Yates et al. NUCLEIC ACIDS RESEARCH
- Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer
- (2019) Changhao Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Predicting Response to Neoadjuvant Chemotherapy in Bladder Cancer
- (2019) Giovanni Motterle et al. European Urology Focus
- Exosome–transmitted long non-coding RNA PTENP1 suppresses bladder cancer progression
- (2018) Rui Zheng et al. Molecular Cancer
- LncRNA as a diagnostic and prognostic biomarker in bladder cancer: a systematic review and meta-analysis
- (2018) Jing Quan et al. OncoTargets and Therapy
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- Regularization Paths for Generalized Linear Models via Coordinate Descent
- (2015) Jerome Friedman et al. Journal of Statistical Software
- pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
- (2014) Paul Geeleher et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search